Expanded Access to Elezanumab
NCT04278235
·
clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Acute Spinal Cord Injury (SCI)
Interventions
DRUG:
Elezanumab
Sponsor
AbbVie